-The Indian Express Yet another depressing charade played out at Lima, Peru, where the 20th conference of the parties (COP) to the United Framework Convention on Climate Change (UNFCCC) concluded on December 14, with a 43-page negotiating text, with several alternative formulations for virtually every provision. It is unlikely that, within the deadline set by the Paris COP in December 2015, an agreed text will be negotiated, especially since Lima has...

-The Asian Age There was a news report not so long ago that ICRISAT (International Crops Research Institute for the Semi-Arid Tropics), an international organisation and part of the CGIAR (Consultative Group on International Agricultural Research) consortium, had entered into an agreement with Gubba Cold Storage Ltd. to set up a private seed bank, the first of its kind in India. No details were available of the terms and conditions under...

-Frontline The Left and other national parties protest against the NDA government's attempts to dilute the MGNREGS by limiting its budget and reducing its reach. IN a rare show of solidarity, representatives of several political parties took issue with the Bharatiya Janata Party-led National Democratic Alliance (NDA) government on its controversial proposal to restructure the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS). The opposition, which was initially confined to the...

-The Hindu Business Line   The closure of three urea producing plants in south India has led to a sharp spike in imports and subsidies In April 2014, the UPA government in its last days, cut off the lifeline of three urea plants. It gave a final push to a ten-year-old trend of replacing domestic urea production with imports. The government-owned Madras Fertilisers, and the private sector units SPIC and MCF closed down...

-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin...